Lancet-话题@MedSci

#Lancet#

4369篇内容 | 4834人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1831244, encodeId=5f7d183124438, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Psychiatry：精神障碍、情绪障碍患者应优先接种COVID-19疫苗, objectType=article, longId=214465, objectId=8981214465e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8981214465e4, replyNumber=0, likeNumber=36, createdTime=2021-11-18, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8981214465e4, moduleTitle=Lancet Psychiatry：精神障碍、情绪障碍患者应优先接种COVID-19疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8981214465e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831430, encodeId=e39e183143080, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Respir Med ：静脉注射免疫球蛋白并不能改善COVID-19相关中重度ARDS患者的预后, objectType=article, longId=292267, objectId=708129226ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=708129226ea4, replyNumber=0, likeNumber=41, createdTime=2022-06-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=708129226ea4, moduleTitle=Lancet Respir Med ：静脉注射免疫球蛋白并不能改善COVID-19相关中重度ARDS患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=708129226ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831090, encodeId=93aa1831090d4, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet：黄体酮保胎治疗的60年之争, objectType=article, longId=209251, objectId=359120925146, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=359120925146, replyNumber=0, likeNumber=28, createdTime=2021-08-08, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=359120925146, moduleTitle=Lancet：黄体酮保胎治疗的60年之争, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=359120925146)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831353, encodeId=1a3a183135314, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Neurol：耐受性差，疗效阴性——不推荐贝沙罗汀治疗复发缓解型多发性硬化症(CCMR ONE), objectType=article, longId=219155, objectId=f5c7219155cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5c7219155cb, replyNumber=0, likeNumber=24, createdTime=2022-01-16, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5c7219155cb, moduleTitle=Lancet Neurol：耐受性差，疗效阴性——不推荐贝沙罗汀治疗复发缓解型多发性硬化症(CCMR ONE), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5c7219155cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831302, encodeId=fae918313027a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！, objectType=article, longId=217212, objectId=a44c21e21243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a44c21e21243, replyNumber=0, likeNumber=28, createdTime=2022-04-08, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a44c21e21243, moduleTitle=Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a44c21e21243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831260, encodeId=35b41831260f9, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：帕妥珠单抗+曲妥珠单抗治疗HER2阳性转移性胆道癌的疗效和安全性, objectType=article, longId=215273, objectId=4e602152e3e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e602152e3e8, replyNumber=0, likeNumber=48, createdTime=2021-11-28, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e602152e3e8, moduleTitle=Lancet Oncol：帕妥珠单抗+曲妥珠单抗治疗HER2阳性转移性胆道癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e602152e3e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831079, encodeId=4f8218310e97c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：英格兰和威尔士监狱COVID-19死亡率相较普通环境高出3.3倍！, objectType=article, longId=208717, objectId=bbf8208e1769, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbf8208e1769, replyNumber=0, likeNumber=27, createdTime=2021-08-03, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbf8208e1769, moduleTitle=Lancet子刊：英格兰和威尔士监狱COVID-19死亡率相较普通环境高出3.3倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbf8208e1769)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831256, encodeId=cea318312563f, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：≥80岁的非转移性去势抵抗性前列腺癌患者是否可使用雄激素受体抑制剂治疗？, objectType=article, longId=215061, objectId=7b66215061fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b66215061fc, replyNumber=0, likeNumber=40, createdTime=2022-02-02, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b66215061fc, moduleTitle=Lancet Oncol：≥80岁的非转移性去势抵抗性前列腺癌患者是否可使用雄激素受体抑制剂治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b66215061fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831329, encodeId=f8611831329bb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Neurology：脑卒中或将成为世界健康“头号杀手”, objectType=article, longId=218318, objectId=b69a21831847, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b69a21831847, replyNumber=0, likeNumber=44, createdTime=2022-08-21, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b69a21831847, moduleTitle=Lancet Neurology：脑卒中或将成为世界健康“头号杀手”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b69a21831847)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831054, encodeId=79d51831054d2, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet infect dis：漱口水可预防男男性活动传播口咽淋病？, objectType=article, longId=208165, objectId=63ab20816564, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63ab20816564, replyNumber=0, likeNumber=51, createdTime=2021-08-04, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63ab20816564, moduleTitle=Lancet infect dis：漱口水可预防男男性活动传播口咽淋病？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63ab20816564)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1830978, encodeId=7ea018309e836, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet：疲劳、乏力、睡眠困难、焦虑及抑郁是新冠肺炎患者康复后常见的异常体征，重症患者肺弥散功能受损, objectType=article, longId=205534, objectId=37df2055344e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37df2055344e, replyNumber=0, likeNumber=54, createdTime=2021-04-23, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37df2055344e, moduleTitle=Lancet：疲劳、乏力、睡眠困难、焦虑及抑郁是新冠肺炎患者康复后常见的异常体征，重症患者肺弥散功能受损, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37df2055344e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831289, encodeId=b85d1831289e5, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：雷莫芦单抗+吉西他滨作为二线疗法可显著延长恶性胸膜间皮瘤患者的生存期！, objectType=article, longId=216812, objectId=832d216812a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=832d216812a4, replyNumber=0, likeNumber=29, createdTime=2021-11-03, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=832d216812a4, moduleTitle=Lancet Oncol：雷莫芦单抗+吉西他滨作为二线疗法可显著延长恶性胸膜间皮瘤患者的生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=832d216812a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831135, encodeId=3520183113548, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet oncol：多种放化疗联合方案治疗局部晚期头颈癌的疗效对比, objectType=article, longId=210448, objectId=c74521044816, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c74521044816, replyNumber=0, likeNumber=0, createdTime=2021-08-29, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c74521044816, moduleTitle=Lancet oncol：多种放化疗联合方案治疗局部晚期头颈癌的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c74521044816)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831579, encodeId=ea6e18315e9ec, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：各种降压药物与癌症风险的相关性, objectType=article, longId=209915, objectId=7bdc209915f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bdc209915f7, replyNumber=0, likeNumber=61, createdTime=2021-11-01, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bdc209915f7, moduleTitle=Lancet Oncol：各种降压药物与癌症风险的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bdc209915f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831000, encodeId=3b1b18310007c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Neurol：八种院前卒中量表评估疑似卒中患者颅内大血管阻塞的表现对比 , objectType=article, longId=206262, objectId=4cb720626287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cb720626287, replyNumber=0, likeNumber=45, createdTime=2021-10-05, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cb720626287, moduleTitle=Lancet Neurol：八种院前卒中量表评估疑似卒中患者颅内大血管阻塞的表现对比 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cb720626287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831222, encodeId=e3f8183122256, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet :COVID-19：疫苗如何对抗 Delta 变体?, objectType=article, longId=213292, objectId=5eb5213292c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eb5213292c5, replyNumber=0, likeNumber=31, createdTime=2022-04-09, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eb5213292c5, moduleTitle=Lancet :COVID-19：疫苗如何对抗 Delta 变体?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eb5213292c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831243, encodeId=800518312432f, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet respirat：同济大学3期临床试验揭示埃克替尼在EGFR突变型晚期NSCLC中的疗效, objectType=article, longId=214456, objectId=4803214456af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4803214456af, replyNumber=0, likeNumber=46, createdTime=2022-06-10, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4803214456af, moduleTitle=Lancet respirat：同济大学3期临床试验揭示埃克替尼在EGFR突变型晚期NSCLC中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4803214456af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831109, encodeId=6ccc183110987, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Neurology：急性缺血性卒中（BP-TARGET）血管内治疗成功后强化降压的安全性和有效性：一项多中心、开放标签、随机对照试验, objectType=article, longId=209639, objectId=abf82096395a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abf82096395a, replyNumber=0, likeNumber=41, createdTime=2021-07-27, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abf82096395a, moduleTitle=Lancet Neurology：急性缺血性卒中（BP-TARGET）血管内治疗成功后强化降压的安全性和有效性：一项多中心、开放标签、随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abf82096395a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831315, encodeId=9198183131580, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：横跨半世纪的研究告诉你，糖尿病患者一生的心血管风险变化, objectType=article, longId=217789, objectId=a3bd21e789bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3bd21e789bc, replyNumber=0, likeNumber=0, createdTime=2022-04-28, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3bd21e789bc, moduleTitle=Lancet子刊：横跨半世纪的研究告诉你，糖尿病患者一生的心血管风险变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3bd21e789bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831321, encodeId=29ef183132171, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！, objectType=article, longId=218057, objectId=abc921805e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abc921805e25, replyNumber=0, likeNumber=40, createdTime=2022-01-13, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abc921805e25, moduleTitle=Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abc921805e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Lancet

2020-05-29

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Psychiatry：精神障碍、情绪障碍患者应优先接种COVID-19疫苗

2021-11-18

zhouqu_8 (审核中...)

前往app查看评论内容

#Lancet#

Lancet Respir Med ：静脉注射免疫球蛋白并不能改善COVID-19相关中重度ARDS患者的预后

2022-06-29

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet：黄体酮保胎治疗的60年之争

2021-08-08

zhaojie88 (审核中...)

前往app查看评论内容

#Lancet#

Lancet Neurol：耐受性差，疗效阴性——不推荐贝沙罗汀治疗复发缓解型多发性硬化症(CCMR ONE)

2022-01-16

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！

2022-04-08

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：帕妥珠单抗+曲妥珠单抗治疗HER2阳性转移性胆道癌的疗效和安全性

2021-11-28

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：英格兰和威尔士监狱COVID-19死亡率相较普通环境高出3.3倍！

2021-08-03

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：≥80岁的非转移性去势抵抗性前列腺癌患者是否可使用雄激素受体抑制剂治疗？

2022-02-02

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Neurology：脑卒中或将成为世界健康“头号杀手”

2022-08-21

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet infect dis：漱口水可预防男男性活动传播口咽淋病？

2021-08-04

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet：疲劳、乏力、睡眠困难、焦虑及抑郁是新冠肺炎患者康复后常见的异常体征，重症患者肺弥散功能受损

2021-04-23

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：雷莫芦单抗+吉西他滨作为二线疗法可显著延长恶性胸膜间皮瘤患者的生存期！

2021-11-03

zhaojie88 (审核中...)

前往app查看评论内容

#Lancet#

Lancet oncol：多种放化疗联合方案治疗局部晚期头颈癌的疗效对比

2021-08-29

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：各种降压药物与癌症风险的相关性

2021-11-01

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Neurol：八种院前卒中量表评估疑似卒中患者颅内大血管阻塞的表现对比

2021-10-05

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet :COVID-19：疫苗如何对抗 Delta 变体?

2022-04-09

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet respirat：同济大学3期临床试验揭示埃克替尼在EGFR突变型晚期NSCLC中的疗效

2022-06-10

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Neurology：急性缺血性卒中（BP-TARGET）血管内治疗成功后强化降压的安全性和有效性：一项多中心、开放标签、随机对照试验

2021-07-27

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：横跨半世纪的研究告诉你，糖尿病患者一生的心血管风险变化

2022-04-28

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！

2022-01-13

科室
- - 订阅+
  - 更多科室
工具
服务